<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32098365</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">502</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9020502</ELocationID><Abstract><AbstractText>Understanding the cellular and molecular basis of selective vulnerability has been challenging, especially for motor neuron diseases. Developing drugs that improve the health of neurons that display selective vulnerability relies on <i>in vivo</i> cell-based models and quantitative readout measures that translate to patient outcome. We initially developed and characterized UCHL1-eGFP mice, in which motor neurons are labeled with eGFP that is stable and long-lasting. By crossing UCHL1-eGFP to amyotrophic lateral sclerosis (ALS) disease models, we generated ALS mouse models with fluorescently labeled motor neurons. Their examination over time began to reveal the cellular basis of selective vulnerability even within the related motor neuron pools. Accumulation of misfolded SOD1 protein both in the corticospinal and spinal motor neurons over time correlated with the timing and extent of degeneration. This further proved simultaneous degeneration of both upper and lower motor neurons, and the requirement to consider both upper and lower motor neuron populations in drug discovery efforts. Demonstration of the direct correlation between misfolded SOD1 accumulation and motor neuron degeneration in both cortex and spinal cord is important for building cell-based assays <i>in vivo</i>. Our report sets the stage for shifting focus from mice to diseased neurons for drug discovery efforts, especially for motor neuron diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Genc</LastName><ForeName>Baris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology and Clinical Neurological Sciences, Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gozutok</LastName><ForeName>Oge</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology and Clinical Neurological Sciences, Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocak</LastName><ForeName>Nuran</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology and Clinical Neurological Sciences, Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozdinler</LastName><ForeName>P Hande</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0003-4125-6013</Identifier><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology and Clinical Neurological Sciences, Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chemistry of Life Processes Institute, Northwestern University, Chicago, IL 60201, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Les Turner ALS Center, Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine Chicago, IL 60611, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG061708</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS085750</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485184">enhanced green fluorescent protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C496976">Uchl1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">corticospinal motor neuron</Keyword><Keyword MajorTopicYN="N">misfolded SOD1</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">selective vulnerability</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32098365</ArticleId><ArticleId IdType="pmc">PMC7072754</ArticleId><ArticleId IdType="doi">10.3390/cells9020502</ArticleId><ArticleId IdType="pii">cells9020502</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kanning K.C., Kaplan A., Henderson C.E. Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 2010;33:409&#x2013;440. doi: 10.1146/annurev.neuro.051508.135722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.051508.135722</ArticleId><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M., Sharma A., Lyashchenko A.K., Shneider N.A. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc. Natl. Acad. Sci. USA. 2016;113:E8316&#x2013;E8325. doi: 10.1073/pnas.1605210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. Off. J. Soc. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochat C., Bernard-Marissal N., Schneider B.L. Selective Vulnerability of Neuronal Subtypes in ALS: A Fertile Ground for the Identification of Therapeutic Targets. Update Amyotroph. Lateral Scler. 2016:165&#x2013;194. doi: 10.5772/63703.</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/63703</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4:49&#x2013;60. doi: 10.1038/nrn1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells C., Brennan S.E., Keon M., Saksena N.K. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases. Front. Mol. Neurosci. 2019;12:271. doi: 10.3389/fnmol.2019.00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00271</ArticleId><ArticleId IdType="pmc">PMC6861308</ArticleId><ArticleId IdType="pubmed">31780895</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S., Atkin J.D. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;649. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Plotkin S.S., Yerbury J.J., Cashman N.R. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F., Soucy G., Lariviere R., Julien J.P. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 2010;113:1188&#x2013;1199. doi: 10.1111/j.1471-4159.2010.06683.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06683.x</ArticleId><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Roselli F., Singh K., Leptien K., Julien J.P., Gros-Louis F., Caroni P. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80&#x2013;96. doi: 10.1016/j.neuron.2013.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes M.F., Kahn J., Israelson A. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proc. Natl. Acad. Sci. USA. 2019;116:14755&#x2013;14760. doi: 10.1073/pnas.1904665116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904665116</ArticleId><ArticleId IdType="pmc">PMC6642395</ArticleId><ArticleId IdType="pubmed">31262807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K., Patel P., Julien J.P. Protective effects of Withania somnifera extract in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2018;309:193&#x2013;204. doi: 10.1016/j.expneurol.2018.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.008</ArticleId><ArticleId IdType="pubmed">30134145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Destroismaisons L., Peyrard S.L., Cadot S., Rouleau G.A., Brown R.H., Jr., Julien J.P., Arbour N., Vande Velde C. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 2013;22:3947&#x2013;3959. doi: 10.1093/hmg/ddt249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt249</ArticleId><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Genc B., Klessner J.L., Ozdinler P.H. Retrograde labeling, transduction, and genetic targeting allow cellular analysis of corticospinal motor neurons: Implications in health and disease. Front. Neuroanat. 2014;8:16. doi: 10.3389/fnana.2014.00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2014.00016</ArticleId><ArticleId IdType="pmc">PMC3972458</ArticleId><ArticleId IdType="pubmed">24723858</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B., Gozutok O., Ozdinler P.H. Complexity of Generating Mouse Models to Study the Upper Motor Neurons: Let Us Shift Focus from Mice to Neurons. Int. J. Mol. Sci. 2019;20:3848. doi: 10.3390/ijms20163848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20163848</ArticleId><ArticleId IdType="pmc">PMC6720674</ArticleId><ArticleId IdType="pubmed">31394733</ArticleId></ArticleIdList></Reference><Reference><Citation>Commisso B., Ding L., Varadi K., Gorges M., Bayer D., Boeckers T.M., Ludolph A.C., Kassubek J., Muller O.J., Roselli F. Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9. eLife. 2018;7 doi: 10.7554/eLife.36892.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36892</ArticleId><ArticleId IdType="pmc">PMC6125125</ArticleId><ArticleId IdType="pubmed">30136928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasvoina M.V., Genc B., Jara J.H., Sheets P.L., Quinlan K.A., Milosevic A., Shepherd G.M., Heckman C.J., Ozdinler P.H. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model. J. Neurosci. Off. J. Soc. Neurosci. 2013;33:7890&#x2013;7904. doi: 10.1523/JNEUROSCI.2787-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2787-12.2013</ArticleId><ArticleId IdType="pmc">PMC3963467</ArticleId><ArticleId IdType="pubmed">23637180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M., Tadokoro T., Navarro M.R., Platoshyn O., Kobayashi Y., Marsala S., Miyanohara A., Juhas S., Juhasova J., Skalnikova H., et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat. Med. 2019 doi: 10.1038/s41591-019-0674-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0674-1</ArticleId><ArticleId IdType="pubmed">31873312</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N., Menon P., Ozdinler P.H., Kiernan M.C., Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat. Rev. Neurol. 2016;12:651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Jr., Robberecht W. Amyotrophic lateral sclerosis: Pathogenesis. Semin. Neurol. 2001;21:131&#x2013;139. doi: 10.1055/s-2001-15260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2001-15260</ArticleId><ArticleId IdType="pubmed">11442322</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:564&#x2013;573. doi: 10.1002/mus.1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.1042</ArticleId><ArticleId IdType="pubmed">11268031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B., Jara J.H., Lagrimas A.K., Pytel P., Roos R.P., Mesulam M.M., Geula C., Bigio E.H., Ozdinler P.H. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci. Rep. 2017;7:41765. doi: 10.1038/srep41765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41765</ArticleId><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Kocak N., Rylaarsdam L.E., Kim K.D., Bigio E.H., Hande Ozdinler P. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Sekerkova G., Yasvoina M.V., Martina M., Ozdinler P.H. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum. Mol. Genet. 2016;25:1074&#x2013;1087. doi: 10.1093/hmg/ddv631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv631</ArticleId><ArticleId IdType="pmc">PMC4764190</ArticleId><ArticleId IdType="pubmed">26755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Genc B., Cox G.A., Bohn M.C., Roos R.P., Macklis J.D., Ulupinar E., Ozdinler P.H. Corticospinal Motor Neurons Are Susceptible to Increased ER Stress and Display Profound Degeneration in the Absence of UCHL1 Function. Cereb Cortex. 2015;25:4259&#x2013;4272. doi: 10.1093/cercor/bhu318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhu318</ArticleId><ArticleId IdType="pmc">PMC4626833</ArticleId><ArticleId IdType="pubmed">25596590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D., DeLoach A., Yadav S., Alkam D., MacNicol M., Singh A., Compadre C.M., Goellner J.J., O&#x2019;Brien C.A., Fahmi T., et al. Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum. Mol. Genet. 2017;26:686&#x2013;701. doi: 10.1093/hmg/ddw429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw429</ArticleId><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce P.I., McGoldrick P., Saccon R.A., Weber W., Fratta P., West S.J., Zhu N., Carter S., Phatak V., Stewart M., et al. A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity. Hum. Mol. Genet. 2015;24:1883&#x2013;1897. doi: 10.1093/hmg/ddu605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu605</ArticleId><ArticleId IdType="pmc">PMC4355022</ArticleId><ArticleId IdType="pubmed">25468678</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlasi R.S., Malik R., Corrales C.I., Tzeplaeff L., Whitelegge J.P., Cashman N.R., Bitan G. Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1 Misfolding and Surprising Behavior of the Antibodies Themselves. ACS Chem. Biol. 2018;13:2794&#x2013;2807. doi: 10.1021/acschembio.8b00729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00729</ArticleId><ArticleId IdType="pmc">PMC6475120</ArticleId><ArticleId IdType="pubmed">30110532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Vande Velde C. Misfolded SOD1 and ALS: Zeroing in on mitochondria. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2012;13:333&#x2013;340. doi: 10.3109/17482968.2012.648645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.648645</ArticleId><ArticleId IdType="pubmed">22471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Semmler S., Broom H.R., Destroismaisons L., Legroux L., Arbour N., Meiering E., Cashman N.R., Vande Velde C. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol. Commun. 2016;4:43. doi: 10.1186/s40478-016-0313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0313-8</ArticleId><ArticleId IdType="pmc">PMC4847257</ArticleId><ArticleId IdType="pubmed">27121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno M.S., Bosco D.A. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell. Neurosci. 2013;7:253. doi: 10.3389/fncel.2013.00253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B., Lehmann M., Beaudin M., Nordstrom U., Saikali S., Julien J.P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Bui A., Saberi S., Lee S.K., Stauffer J., McAlonis-Downes M., Schulte D., Pizzo D.P., Parone P.A., Cleveland D.W., et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 2017;134:97&#x2013;111. doi: 10.1007/s00401-017-1688-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1688-8</ArticleId><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y., Homma K., Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv. Biol. Regul. 2016;60:95&#x2013;104. doi: 10.1016/j.jbior.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.10.006</ArticleId><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Marissal N., Sunyach C., Marissal T., Raoul C., Pettmann B. Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice. Neurobiol. Dis. 2015;73:130&#x2013;136. doi: 10.1016/j.nbd.2014.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.09.009</ArticleId><ArticleId IdType="pubmed">25277755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M.J., Mu E.W.H., Lavidis N.A., Noakes P.G., Bellingham M.C. Size-Dependent Vulnerability of Lumbar Motor Neuron Dendritic Degeneration in SOD1(G93A) Mice. Anat. Rec. 2019 doi: 10.1002/ar.24255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.24255</ArticleId><ArticleId IdType="pubmed">31509351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruegsegger C., Maharjan N., Goswami A., Filezac de L&#x2019;Etang A., Weis J., Troost D., Heller M., Gut H., Saxena S. Aberrant association of misfolded SOD1 with Na(+)/K(+)ATPase-alpha3 impairs its activity and contributes to motor neuron vulnerability in ALS. Acta Neuropathol. 2016;131:427&#x2013;451. doi: 10.1007/s00401-015-1510-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1510-4</ArticleId><ArticleId IdType="pubmed">26619836</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler S., Gagn&#xe9; M., Garg P., Pickles S.R., Baudouin C., Hamon-Keromen E., Destroismaisons L., Khalfallah Y., Chaineau M., Caron E., et al. The E3 ubiquitin ligase TRAF6 is a novel interacting protein of amyotrophic lateral sclerosis-linked misfolded SOD1. bioRxiv. 2019:780460. doi: 10.1101/780460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/780460</ArticleId></ArticleIdList></Reference><Reference><Citation>Filezac de L&#x2019;Etang A., Maharjan N., Cordeiro Brana M., Ruegsegger C., Rehmann R., Goswami A., Roos A., Troost D., Schneider B.L., Weis J., et al. Marinesco-Sjogren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. Nat. Neurosci. 2015;18:227&#x2013;238. doi: 10.1038/nn.3903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3903</ArticleId><ArticleId IdType="pubmed">25559081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Marissal N., Moumen A., Sunyach C., Pellegrino C., Dudley K., Henderson C.E., Raoul C., Pettmann B. Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS. J. Neurosci. Off. J. Soc. Neurosci. 2012;32:4901&#x2013;4912. doi: 10.1523/JNEUROSCI.5431-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5431-11.2012</ArticleId><ArticleId IdType="pmc">PMC6620921</ArticleId><ArticleId IdType="pubmed">22492046</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung Y.T., Peng K.C., Chen Y.C., Yen Y.P., Chang M., Thams S., Chen J.A. Mir-17 approximately 92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Cell Stem Cell. 2019;25:193&#x2013;209.e7. doi: 10.1016/j.stem.2019.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.04.016</ArticleId><ArticleId IdType="pubmed">31155482</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Parone P.A., Da Cruz S., Han J.S., McAlonis-Downes M., Vetto A.P., Lee S.K., Tseng E., Cleveland D.W. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. Off. J. Soc. Neurosci. 2013;33:4657&#x2013;4671. doi: 10.1523/JNEUROSCI.1119-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1119-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711648</ArticleId><ArticleId IdType="pubmed">23486940</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvin C.W., Kim R.B., Mitchell C.S. Seeking homeostasis: Temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice. Front. Cell. Neurosci. 2015;9:248. doi: 10.3389/fncel.2015.00248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00248</ArticleId><ArticleId IdType="pmc">PMC4486844</ArticleId><ArticleId IdType="pubmed">26190973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A., Spiller K.J., Towne C., Kanning K.C., Choe G.T., Geber A., Akay T., Aebischer P., Henderson C.E. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Morisaki Y., Niikura M., Watanabe M., Onishi K., Tanabe S., Moriwaki Y., Okuda T., Ohara S., Murayama S., Takao M., et al. Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9. Sci. Rep. 2016;6:27354. doi: 10.1038/srep27354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27354</ArticleId><ArticleId IdType="pmc">PMC4893611</ArticleId><ArticleId IdType="pubmed">27264390</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirren E., Aebischer J., Rochat C., Towne C., Schneider B.L., Aebischer P. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice. Ann. Clin. Transl. Neurol. 2015;2:167&#x2013;184. doi: 10.1002/acn3.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.162</ArticleId><ArticleId IdType="pmc">PMC4338957</ArticleId><ArticleId IdType="pubmed">25750921</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust K.D., Salazar D.L., Likhite S., Ferraiuolo L., Ditsworth D., Ilieva H., Meyer K., Schmelzer L., Braun L., Cleveland D.W., et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. J. Am. Soc. Gene Ther. 2013;21:2148&#x2013;2159. doi: 10.1038/mt.2013.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId><ArticleId IdType="pmc">PMC3863799</ArticleId><ArticleId IdType="pubmed">24008656</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannitti T., Scarrott J.M., Likhite S., Coldicott I.R.P., Lewis K.E., Heath P.R., Higginbottom A., Myszczynska M.A., Milo M., Hautbergue G.M., et al. Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS. Mol. Nucleic Acids. 2018;12:75&#x2013;88. doi: 10.1016/j.omtn.2018.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2018.04.015</ArticleId><ArticleId IdType="pmc">PMC6023790</ArticleId><ArticleId IdType="pubmed">30195799</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A., Cole T., Wegener A.J., Tomassy G.S., Setnicka A., Farley B.J., Schoch K.M., Hoye M.L., Shabsovich M., Sun L., et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J. Clin. Investig. 2018;128:3558&#x2013;3567. doi: 10.1172/JCI99081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99081</ArticleId><ArticleId IdType="pmc">PMC6063493</ArticleId><ArticleId IdType="pubmed">30010620</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Pestronk A., David W., Rothstein J., Simpson E., Appel S.H., Andres P.L., Mahoney K., Allred P., Alexander K., et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M., Simone C., Rizzo F., Ulzi G., Ramirez A., Rizzuti M., Bordoni A., Bucchia M., Gatti S., Bresolin N., et al. Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype. Sci. Rep. 2016;6:21301. doi: 10.1038/srep21301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21301</ArticleId><ArticleId IdType="pmc">PMC4754711</ArticleId><ArticleId IdType="pubmed">26878886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralph G.S., Radcliffe P.A., Day D.M., Carthy J.M., Leroux M.A., Lee D.C., Wong L.F., Bilsland L.G., Greensmith L., Kingsman S.M., et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 2005;11:429&#x2013;433. doi: 10.1038/nm1205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1205</ArticleId><ArticleId IdType="pubmed">15768029</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoul C., Abbas-Terki T., Bensadoun J.C., Guillot S., Haase G., Szulc J., Henderson C.E., Aebischer P. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat. Med. 2005;11:423&#x2013;428. doi: 10.1038/nm1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1207</ArticleId><ArticleId IdType="pubmed">15768028</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B., Brown R.H., Jr. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci. Lett. 2017;636:32&#x2013;39. doi: 10.1016/j.neulet.2016.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.059</ArticleId><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yang B., Qiu L., Yang C., Kramer J., Su Q., Guo Y., Brown R.H., Jr., Gao G., Xu Z. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:668&#x2013;681. doi: 10.1093/hmg/ddt454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt454</ArticleId><ArticleId IdType="pmc">PMC3888258</ArticleId><ArticleId IdType="pubmed">24108104</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Guo M., Yi L., Liu Y., Li Z., Ma Y., Zhang G., Liu Y., Bu H., Song X., et al. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model. Gene. 2019 doi: 10.1038/s41434-019-0116-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41434-019-0116-1</ArticleId><ArticleId IdType="pubmed">31819203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>